Proline-rich vaccine candidate antigen of Coccidioides immitis: conservation among isolates and differential

T Peng1, K I Orsborn, M J Orbach

  • 1Research and Medical Services, VA Medical Center, Tucson, Arizona, USA.

Insights

A proline-rich antigen (PRA) shows increased expression during Coccidioides immitis development, suggesting its potential for vaccines. Genetic analysis reveals variations among isolates, but most are covered by PRA-based tests.

Area of Science:

  • Mycology
  • Immunology
  • Molecular Biology

Background:

  • Coccidioides immitis is a fungal pathogen causing coccidioidomycosis.
  • A proline-rich antigen (PRA) has demonstrated protective effects in mouse models against C. immitis.
  • Understanding antigen expression and genetic diversity is crucial for developing effective vaccines.

Purpose of the Study:

  • To analyze the differential expression of the PRA gene during C. immitis growth stages.
  • To investigate the genetic variation of the PRA gene among different C. immitis isolates.
  • To assess the potential of PRA-based vaccines against diverse C. immitis strains.

Main Methods:

  • Northern blot analysis of RNA from various growth stages.
  • Cloning of the PRA gene from the Silveira strain.
  • DNA sequencing of polymerase chain reaction products from multiple isolates.
  • Southern blot analysis to detect genetic heterogeneity.

Main Results:

  • PRA mRNA levels increased as C. immitis spherules matured from mycelia.
  • Significant genetic heterogeneity was observed among different C. immitis isolates.
  • The Silveira strain showed notable differences from other California isolates but minimal variation from non-California isolates.
  • Only one base substitution impacted the protein sequence across analyzed isolates.

Conclusions:

  • The expression pattern of PRA correlates with the protective efficacy of whole-cell vaccines.
  • PRA-based diagnostic tests and vaccines are likely to be effective against a broad range of C. immitis isolates.
  • Genetic variations in PRA do not significantly compromise its potential as a universal vaccine candidate.

Related Concept Videos